<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 3, 2000
-------------
FUTUREBIOTICS, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-24530 11-3205937
- -------------------------------------------------------------------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
Formation)
145 Ricefield Lane, Hauppauge, NY 11788
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (516) 273-2630
--------------
N/A
- --------------------------------------------------------------------------------
(Former name or former address, if changes since last report)
- --------------------------------------------------------------------------------
<PAGE>
Item 5. Other Events.
The Company announced that it has received notification from The Nasdaq
Stock Market that the Company's securities were delisted today from The Nasdaq
SmallCap Market. Specifically, the Company was advised that it has failed to
maintain a public float of 500,000 shares of common stock. The Company believes
that its securities will trade on the OTC Bulletin Board.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits.
(i) Press Release dated April 3, 2000.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly authorized and caused the undersigned to sign this
Report on the Registrant's behalf.
FUTUREBIOTICS, INC.
By:/s/ Reginald Spinello
------------------------
Reginald Spinello
Chief Executive Officer
Dated: April 3, 2000
<PAGE>
Contact: Reginald Spinello
President
Futurebiotics Inc.
(516) 273-2630
FOR IMMEDIATE RELEASE
- ---------------------
FUTUREBIOTICS, INC. ANNOUNCES DELISTING FROM THE NASDAQ
SMALLCAP MARKET
Hauppauge, New York, April 3, 2000 --- Futurebiotics, Inc. (NASDAQ:
VITK) announced that it has received notification from The Nasdaq Stock Market
that the Company's securities were delisted today from The Nasdaq SmallCap
Market. Specifically, the Company was advised that it has failed to maintain a
public float of 500,000 shares of common stock. The Company believes that its
securities will trade on the OTC Bulletin Board.
Futurebiotics is engaged in the distribution, marketing and sales of
vitamins, minerals, herbal formulations and specialty nutritional supplements,
which it markets principally to health food stores through regional
distributors.
Statements in this release that are not statements of historical or
current fact constitute "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Such forward-looking
statements involve known and unknown risks, uncertainties and other unknown
factors that could cause the actual results of the Company to be materially
different from the historical results or from any future results expressed or
implied by such forward-looking statements. In addition to statements that
explicitly describe such risks and uncertainties, readers are urged to consider
statements labeled with the terms "believes," "belief," "expects," "intends,"
"anticipates" or "plans" to be uncertain and forward-looking. The
forward-looking statements contained herein are also subject generally to other
risks and uncertainties that are described from time to time in Futurebiotics'
reports and registration statements filed with the Securities and Exchange
Commission.
******
